Government Shutdown Leads to Insulin Rationing

Government workers are increasingly unable to afford basic necessities like food, power, and critical medications like insulin.

Congressman Introduces “Insulin Access For All Act” for Medicaid and Medicare Beneficiaries

Representative Bobby Rush (D-Ill) introduced the Insulin Access For All Act to eliminate the cost-sharing requirement for patients on Medicare and Medicaid

CW Star Unveils Teen Superheroes with Disabilities

Austin Basis details his comic book series "The Kinetix," which features a protagonist who fights crime while maintaining his Type 1 diabetes.

Research Team Delays Onset of Type 1 Diabetes in Mice

Dr. Massimo Pietropaolo and his team of experimenters at Baylor College of Medicine and the University of Michigan Medical School have determined that certain B cells may have the capacity to delay the onset of T1D.

New Study Reveals the Power of the Diabetes Online Community

You may know the power of the diabetes online community, but does your doctor? Do experts understand what it really means when community members build relationships through social media in the #DOC?

National Health Services To Offer Free Glucose Monitors for T1D in the UK

Beginning April 1, people with Type 1 diabetes in the UK will have the FreeStyle Libre system completely covered, ending issues with access many are currently facing.

Global Diabetes Non-Profit Beyond Type 1 Celebrates World Diabetes Day With Guiness World Record Attempt

Beyond Type 1 is celebrating Sir Frederick Banting’s 127th birthday on Wednesday, November 14th with a coalition of almost 50 organizations attempting to break the Guinness World Record for most contributions to an e-greeting card.

Diabeloop Obtains CE Marking for DBLG1

Diabeloop, a French medical technology company that specializes in creating accessible innovations for the Type 1 diabetes community, has obtained CE marking for its DBLG1 System.

How much does it cost to produce insulin?

A recent study sets prices for the future of biosimilars.

Abbott’s FreeStyle Libre Gains CE Mark In Europe

Earlier this month, Abbott announced that its FreeStyle Libre 2 system had secured CE Mark clearance in the European Union. The system will be launched on a rolling basis throughout Europe, starting in the coming weeks, according to the company.

Research Shows Fridges Might Be Destroying Insulin

A 16-month study has shown that 79% of insulin is kept at temperatures outside of the recommended range. Insulin stored in the fridge is at a much higher risk.

ViaCyte Secures $80 Million in Funding to Further Cell-Based Treatment for Diabetes

ViaCyte is leading the charge in stem cell research and regenerative medicine. Their goal? Cell-based long term diabetes treatments - a “functional cure” for Type 1 diabetes.

$10 Million Grant to ViaCyte from Gore Supports Cell-Based Treatment for Diabetes

Today, ViaCyte and W.L. Gore & Associates announced a $10 million investment by Gore into ViaCyte. This is the second multimillion dollar investment by Gore, following a first in 2017.

CRISPR Therapeutics and ViaCyte’s Strategic Collaboration to Develop Gene‐Edited Stem Cell‐Derived Therapy for Diabetes

Yesterday, CRISPR Therapeutics (NASDAQ: CRSP), a biopharmaceutical company that develops transformative gene‐based medicines for serious diseases, and ViaCyte, Inc., a regenerative medicine company, announced their collaboration.

T1D Care in the Wake of Typhoon Mangkhut

Typhoon Mangkhut has slammed the Philippines, Hong Kong and continues a destruction path across Southern China.